[ DBS System raises $2.52M in Series A funding ]
DBS System has raised $2.52 million in Series A funding.
Founded in 2010, DBS System is a meditech startup that offers a range of drug screening, biomarker detection, and genetic testing services to its clients. DBS System launched its first product HemaXis DB for whole blood collection at the end of 2015 with sales to pharmaceutical companies and research hospital labs who tested and developed protocols for the analysis that would be run on the blood samples collected by the device.
With this investment, DBS System will industrialize its second generation HemaXis blood collection device.
|Founder / CEO||Eric Ödman|
|Investors||Nest Collective Foundation|
|investiere | Verve Capital Partners AG|